Argent Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$316K Sell
4,085
-50
-1% -$4.03K 0.09% 170
2017
Q4
$349K Buy
4,135
+75
+2% +$6.38K 0.09% 162
2017
Q3
$347K Hold
4,060
0.1% 160
2017
Q2
$334K Buy
4,060
+300
+8% +$24.5K 0.09% 164
2017
Q1
$316K Buy
+3,760
New +$301K 0.09% 169

Other funds holding LLY

Argent Trust's LLY Position: Q1 2018 in Review

Argent Trust reduced its Eli Lilly (LLY) stake by 1.2% in Q1 2018, selling an estimated $4.03K and leaving 4,085 shares worth $316K. The position accounts for 0.09% of the portfolio, ranked #170.

Argent Trust first reported a position in LLY in Q1 2017 and has held it in 5 quarters since. The position peaked at $349K in Q4 2017. 1,333 funds tracked by Wall St. Rank hold LLY as of Q1 2018.

  • Argent Trust held 4,085 shares of Eli Lilly worth $316K as of Q1 2018.
  • Argent Trust sold 50 Eli Lilly shares in Q1 2018, an estimated $4.03K.
  • Eli Lilly made up 0.09% of Argent Trust's portfolio in Q1 2018, its #170 holding.
  • Argent Trust first reported a position in Eli Lilly in Q1 2017 and has held it in 5 quarters since.
  • Argent Trust's Eli Lilly position peaked at $349K in Q4 2017.
  • 1,333 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.